Eye Movement Desensitization and Reprocessing on Autoimmune Thyroiditis in Adults

• Status: Completed
• Trial end date: 2021-03-23
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate whether Eye Movement Desensitization and Reprocessing (EMDR) is effective in decreasing the level of autoantibodies of patients with autoimmune thyroiditis. The investigators hypothesize that processing traumatic memories from events that happened before the illness onset will have a positive impact first on the psyche (a) by decreasing the level of dissociation, alexithymia, anger, and (b) by increasing the quality of life and emotional regulation, than those in the control group. Secondly, it will have an impact on the biological level, by decreasing the level of autoantibodies, antithyroglobulin antibody (anti-Tg) and anti-thyroid peroxidase antibody (anti-TPO), which are the main antibodies detected in chronic autoimmune thyroiditis.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Bucharest

Criteria

Inclusion Criteria:

• aged 18-55 years;

• confirmed autoimmune thyroiditis diagnosis

• at least one biological marker Anti-thyroid peroxidase (anti-TPO) antibodies or thyroglobulin antibodies (TgAb) exceeds the reference range

Exclusion Criteria:

• the presence of psychotic symptoms

• currently receiving another form of psychological treatment;

• under psychotropic medication;

• neurodevelopmental disorders (intellectual disability, communication disorders, autism spectrum disorders, ADHD);

• neurocognitive disorders;

• substance abuse;

• serious legal or health issues that would prevent from regularly attending

• patients with autoimmune thyroiditis with biological markers within the reference range